COVID-19 Preprints

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent preprints published on COVID-19.

January 16, 2022
Preprint
Open Access

Waning COVID-19 Vaccine Effectiveness for BNT162b2 and CoronaVac in Malaysia: An Observational Study

MedRxiv : the Preprint Server for Health Sciences
J. L. SuahS. Sivasampu
January 16, 2022
Preprint
Open Access

A prospective, single-center study to evaluate the clinical performance of Meril ABFind in individuals vaccinated against COVID-19

MedRxiv : the Preprint Server for Health Sciences
Jayanthi ShastriH. Gupta
January 16, 2022
Preprint
Open Access

Development of an effective immune response in adults with Down Syndrome after SARS-CoV-2 vaccination

MedRxiv : the Preprint Server for Health Sciences
L. Esparcia-PinedoArantzazu Alfranca
January 16, 2022
Preprint
Open Access

Distinct Vaccine Efficacy Rates Among Health Care Workers During a COVID-19 Outbreak in Jordan

MedRxiv : the Preprint Server for Health Sciences
Iyad SultanA. Mansour
January 16, 2022
Preprint
Open Access

Waning Effectiveness of SARS-CoV-2 mRNA Vaccines in Older Adults: A Rapid Review

MedRxiv : the Preprint Server for Health Sciences
E. NanishiA. Ozonoff
January 16, 2022
Preprint
Open Access

Using Mobile Phone-based Text Message to Recruit Representative Samples: Assessment of a Cross-Sectional Survey about the COVID-19 Vaccine Hesitation.

MedRxiv : the Preprint Server for Health Sciences
Carlos Izaias Sartorao FilhoL. E. G. Cachoni
January 16, 2022
Preprint
Open Access

Resilient T cell responses to B.1.1.529 (Omicron) SARS-CoV-2 variant

MedRxiv : the Preprint Server for Health Sciences
M. JergovicJanko Nikolich-Zugich
January 16, 2022
Preprint
Open Access

Background incidence rates of adverse events of special interest related to COVID-19 vaccines in Ontario, Canada, 2015 to 2020, to inform COVID-19 vaccine safety surveillance

MedRxiv : the Preprint Server for Health Sciences
S. NasreenJeffrey C. Kwong
January 15, 2022
Preprint
Open Access

Implementation of a Rapid RT-LAMP Saliva-based SARS-CoV-2 Testing Program in the Workplace

MedRxiv : the Preprint Server for Health Sciences
Bradley W.M. CookS. S. Theriault
January 15, 2022
Preprint
Open Access

Improved prediction of new COVID-19 cases using a simple vector autoregressive model: Evidence from seven New York State counties

MedRxiv : the Preprint Server for Health Sciences
Harutaka Takahashi, T. Kitaoka
January 15, 2022
Preprint
Open Access

COVID MED - An Early Pandemic Trial of Losartan for Hospitalized COVID-19 Patients

MedRxiv : the Preprint Server for Health Sciences
Daniel FreilichA. Gadomski
January 15, 2022
Preprint
Open Access

Validation of a clinical and genetic model for predicting severe COVID-19

MedRxiv : the Preprint Server for Health Sciences
Gillian S Dite Lifelines Corona Research Initiative
January 15, 2022
Preprint
Open Access

Generation of novel SARS-CoV-2 variants on B.1.1.7 lineage in three patients with advanced HIV disease

MedRxiv : the Preprint Server for Health Sciences
Anna C RiddellT. Cutino-Moguel
January 15, 2022
Preprint
Open Access

Comparison of Antibody Response Durability of mRNA-1273, BNT162b2, and Ad26.COV2.S SARS-CoV-2 Vaccines in Healthcare Workers

MedRxiv : the Preprint Server for Health Sciences
Wendy M BrunnerA. M. Gadomski
January 14, 2022
Preprint
Open Access

High-cited favorable studies for COVID-19 treatments ineffective in large trials

MedRxiv : the Preprint Server for Health Sciences
John P.A. Ioannidis
January 14, 2022
Preprint
Open Access

The risk of SARS-CoV-2 Omicron variant emergence in low and middle-income countries (LMICs)

MedRxiv : the Preprint Server for Health Sciences
Kaiming BiL. A. Meyers
January 14, 2022
Preprint
Open Access

Simple risk scores to predict hospitalization or death in outpatients with COVID-19

MedRxiv : the Preprint Server for Health Sciences
Mark EbellA. Kieber-Emmons
January 14, 2022
Preprint
Open Access

SARS-CoV-2 Omicron Neutralization After Heterologous Vaccine Boosting

MedRxiv : the Preprint Server for Health Sciences
Kirsten E LykeD. Montefiori
January 14, 2022
Preprint
Open Access

Immunosuppression impaired the immunogenicity of inactivated SARS-CoV-2 vaccine in non-dialysis kidney disease patients

MedRxiv : the Preprint Server for Health Sciences
Zijie ZhangZijie Zhang

Sign up to follow this feed and discover related papers.

Related Feeds

AI-driven COVID-19 Management

Artificial intelligence (AI) offers a powerful new tool that could potentially be instrumental in controling and managing the SARS-CoV-2 virus. The papers in this feed report on the applications of AI to the current pandemic, which may be able to predict the location of the next outbreak, or facilitate new drug design.

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

COVID-19 Cardiovascular Complications

Growing evidence shows that COVID-19 can result in serious complications affecting the cardiovascular system, including dysrhythmias, myocarditis, acute myocardial infarction, and heart failure. This feed follows studies investigating the effects of SARS-CoV-2 infection on the heart.

COVID-19 Clinical Diagnosis

COVID-19 patients typically present with high fever and a persistent cough. This feed focuses on clinical diagnosis, including RT-PCR testing for the presence of SARS-CoV-2 and radiographic assessment of lungs.

COVID-19 Clinical Management

While most COVID-19 infections cause only mild to moderate symptoms, severely affected patients, such as those presenting with pneumonia, ARDS or septic shock, require hospitalization. This feed focuses on clinical management of patients using oxygen therapy, ventilation, and other treatment strategies, and covers some medical case reports.

COVID-19 Comorbidities

COVID-19 represents a particular challenge to people with serious chronic medical conditions such as diabetes, hypertension, cardiovascular disease, and chronic lung disease. Research into the intersection between comorbidities and COVID-19 is focusing on risks and treatment outcomes for these patients.

COVID-19 Complications

A growing number of complications associated with COVID-19 has been identified. This feed focuses primarily on cardiovascular and respiratory manifestations in severely ill patients.

COVID-19 Covalescent Plasma Therapy

Convalescent plasma therapy, where passive polyclonal antibody obtained from recovered patients are used to provide immediate immunity, has been tested in respiratory infections such as the 2009-2010 H1N1 influenza virus pandemic and the 2003 SARS-CoV-1 epidemic. This feed follows ongoing research efforts and clinical trials exploring covalescent plasma therapy as a potential treatment strategy for COVID-19.

COVID-19 Epidemiology and Demography

Epidemiological studies play a crucial role in understanding and managing the progression of COVID-19. Research followed in this feed includes studies of transmission dynamics and the change of the basic reproductive number (R) as new pubic health measures take effect.

COVID-19 Immune Response

Understanding the innate and acquired immune response to SARS-CoV-2 is essential for development of COVID-19 therapeutic treatment and design of prophylactic vaccines. This feed surfaces immunological studies, including studies into the cytokine storm that has been observed in severely ill patients.

© 2022 Meta ULC. All rights reserved
/feed-previews/covid-19-preprints/c3b66c4c-2f84-4fbe-b290-b39f2aa7d5d4